Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00226941
Status:
TERMINATED
Last Update Posted:
2017-12-08
First Post:
2005-09-08
Brief Title:
A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin Capecitabine and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
Sponsor:
George Albert Fisher
Organization:
Stanford University
Organization Data
Organization:
Stanford University
Class:
OTHER
Study ID:
IRB-12426
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
George Albert Fisher
Lead Sponsor Class:
OTHER
Responsible Party:
George Albert Fisher
Responsible Party Title:
Professor of Medicine and Colleen Haas Chair in the School of Medicine
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Stanford University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bristol-Myers Squibb | INDUSTRY |